Long-term treatment by ACE inhibitors and angiotensin receptor blockers in children with Alport syndrome

详细信息    查看全文

• 作者：Yanqin Zhang ; Fang Wang ; Jie Ding ; Hongwen Zhang ; Xiaoyu Liu…
• 关键词：Alport syndrome ; Children ; Proteinuria ; ACE inhibitor ; Angiotensin receptor blocker
• 刊名：Pediatric Nephrology
• 出版年：2016
• 出版时间：January 2016
• 年：2016
• 卷：31
• 期：1
• 页码：67-72
• 全文大小：288 KB
• 参考文献：1.Barker DF, Hostikka SL, Zhou J, Chow LT, Oliphant AR, Gerken SC, Gregory MC, Skolnick MH, Atkin CL, Tryggvason K (1990) Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 248:1224鈥?227CrossRef PubMed
  2.Nagel M, Nagorka S, Gross O (2005) Novel COL4A5, COL4A4, and COL4A3 mutations in Alport syndrome. Hum Mutat 26:60CrossRef PubMed
  3.Mochizuki T, Lemmink HH, Mariyama M, Antignac C, Gubler MC, Pirson Y, Verellen-Dumoulin C, Chan B, Schr枚der CH, Smeets HJ (1994) Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet 8:77鈥?1CrossRef PubMed
  4.Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, Weber M, Gross O, Netzer KO, Flinter F, Pirson Y, Verellen C, Wieslander J, Persson U, Tryggvason K, Martin P, Hertz JM, Schr枚der C, Sanak M, Krejcova S, Carvalho MF, Saus J, Antignac C, Smeets H, Gubler MC (2000) X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males. J Am Soc Nephrol 11:649鈥?57PubMed
  5.Wang F, Zhao D, Ding J, Zhang H, Zhang Y, Yu L, Xiao H, Yao Y, Zhong X, Wang S (2012) Skin biopsy is a practical approach for the clinical diagnosis and molecular genetic analysis of x-linked Alport鈥檚 syndrome. J Mol Diagn 14:586鈥?93CrossRef PubMed
  6.Zhang Y, Wang F, Ding J, Zhang H, Zhao D, Yu L, Xiao H, Yao Y, Zhong X, Wang S (2012) Genotype-phenotype correlations in 17 Chinese patients with autosomal recessive Alport syndrome. Am J Med Genet A 158A:2188鈥?193CrossRef PubMed
  7.Kashtan CE, Ding J, Gregory M, Gross O, Heidet L, Knebelmann B, Rheault M, Licht C, Alport Syndrome Research Collaborative (2013) Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative. Pediatr Nephrol 28:5鈥?1PubMedCentral CrossRef PubMed
  8.Gross O, Licht C, Anders HJ, Hoppe B, Beck B, T枚nshoff B, H枚cker B, Wygoda S, Ehrich JH, Pape L, Konrad M, Rascher W, D枚tsch J, M眉ller-Wiefel DE, Hoyer P, Study Group Members of the Gesellschaft f眉r P盲diatrische Nephrologie, Knebelmann B, Pirson Y, Grunfeld JP, Niaudet P, Cochat P, Heidet L, Lebbah S, Torra R, Friede T, Lange K, M眉ller GA, Weber M (2012) Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy. Kidney Int 81:494鈥?01CrossRef PubMed
  9.Webb NJ, Shahinfar S, Wells TG, Massaad R, Gleim GW, McCrary Sisk C, Lam C (2013) Losartan and enalapril are comparable in reducing proteinuria in children with Alport syndrome. Pediatr Nephrol 28:737鈥?43CrossRef PubMed
  10.Li JG, Ding J, Wang F, Zhang HW (2009) Drugs controlling proteinuria of patients with Alport syndrome. World J Pediatr 5:308鈥?11CrossRef PubMed
  11.Proesmans W, Knockaert H, Trouet D (2000) Enalapril in paediatric patients with Alport syndrome: 2 years鈥?experience. Eur J Pediatr 159:430鈥?33CrossRef PubMed
  12.Webb NJ, Lam C, Shahinfar S, Strehlau J, Wells TG, Gleim GW, Le Bailly De Tilleghem C (2011) Efficacy and safety of losartan in children with Alport syndrome鈥攔esults from a subgroup analysis of a prospective, randomized, placebo- or amlodipine-controlled trial. Nephrol Dial Transplant 26:2521鈥?526CrossRef PubMed
  13.Adler L, Mathew R, Futterweit S, Frank R, Gauthier BG, Kashtan CE, Trachtman H (2002) Angiotensin converting enzyme inhibitor therapy in children with Alport syndrome: effect on urinary albumin, TGF-beta, and nitrite excretion. BMC Nephrol 3:2PubMedCentral CrossRef PubMed
  14.Proesmans W, Van Dyck M (2004) Enalapril in children with Alport syndrome. Pediatr Nephrol 19:271鈥?75CrossRef PubMed
  
• 作者单位：Yanqin Zhang (1)
  Fang Wang (1)
  Jie Ding (1)
  Hongwen Zhang (1)
  Xiaoyu Liu (1)
  Suxia Wang (2)
  Huijie Xiao (1)
  Yong Yao (1)
  Jingcheng Liu (1)
  Xuhui Zhong (1)
  Na Guan (1)
  Baige Su (1)
  Guohong Wu (1)
  Lixia Yu (1)
  
  1. Department of Pediatrics, Peking University First Hospital, No. 1, Xi An Men Da Jie, Beijing, 100034, People鈥檚 Republic of China
  2. Department of Electron Microscopy, Peking University First Hospital, Beijing, China
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Pediatrics
  
• 出版者：Springer Berlin / Heidelberg
• ISSN：1432-198X

文摘

Background The aim of this study was to analyze the long-term efficacy and safety of angiotensin-converting enzyme inhibitor (ACEi) and ACEi + angiotensin receptor blocker (ARB) treatments in a cohort of children with Alport syndrome (AS).